ArticleInternational journal of breast cancer2021

Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis.

Sara Khoshroo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.